BioNexus Gene Lab (BGLC) Restructuring Costs (2020 - 2025)

BioNexus Gene Lab has disclosed Restructuring Costs across 6 years of filings, most recently posting $181095.0 for Q4 2025.

• In Q4 2025, Restructuring Costs rose 9.14% year-over-year to $181095.0; the TTM figure through Dec 2025 stood at $1.5 million (down 16.23% YoY), while the FY2025 annual figure was $1.5 million, down 16.23% from the prior year.
• Restructuring Costs came in at $181095.0 for Q4 2025 at BioNexus Gene Lab, down from $445691.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $3.1 million in Q3 2023 to a low of -$2.0 million in Q4 2023.
• Average Restructuring Costs over 5 years is $440918.4, with a median of $416666.5 recorded in 2021.
• The largest YoY upside for Restructuring Costs was 635.9% in 2023 against a maximum downside of 506.52% in 2023.
• Over 5 years, Restructuring Costs stood at $182831.0 in 2021, then jumped by 166.84% to $487858.0 in 2022, then plunged by 506.52% to -$2.0 million in 2023, then jumped by 108.37% to $165932.0 in 2024, then increased by 9.14% to $181095.0 in 2025.
• Per Business Quant data, the three most recent Restructuring Costs figures were $181095.0 in Q4 2025, $445691.0 in Q3 2025, and $516790.0 in Q2 2025.